Grant: CIHR Fellowship
McGill University
$71,250.00
Targeting glutmate-dependent translation elongation in brain tumours.
EF 2013-14
Résumé
Proteins are the functional units in the cell that drive metabolism. In cancer, the cellular machinery that makes proteins is often deregulated. The result is increased synthesis of proteins that leads to runaway growth and proliferation. Normally, this deregulated growth would turn on specific switches that lead the cell to commit suicide. However, some cancer cells including brain tumour cells are able to undermine this process by dampening their overactive protein-making machinery. This increases resistance of cancers to chemotherapies. It is not clear how the cell achieves this and the main goal of the work described in this proposal is to understand how this process works at the molecular level. Interestingly, levels of glutamate, a non-essential amino acid may be involved in increasing chemotherapeutic resistance of brain tumours. Aggressive brain tumours such as medulloblastomas and glioblastomas are known to secrete large amounts of glutamate, however its impact on tumour cells has not been well-studied. We will use human tumour cell models to investigate whether glutamate is involved in altering the protein synthesis machinery and if so, determine which proteins are most affected in this context. We will also test whether the efficiency of current chemotherapies that target the protein synthesis machinery can be increased by combined treatment with inhibitors of glutamate signalling which are already in clinical trials for the treatment of autistic disorders.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
301013
Name
Graber Tyson
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Targeting glutmate-dependent translation elongation in brain tumours.
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$71,250
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cancer; Glioblastoma; Glutamate; Medulloblastoma; Metabotropic Glutamate Receptor; Protein Synthesis; Ribosome Profiling; Translation Elongation
Abstract
Proteins are the functional units in the cell that drive metabolism. In cancer, the cellular machinery that makes proteins is often deregulated. The result is increased synthesis of proteins that leads to runaway growth and proliferation. Normally, this deregulated growth would turn on specific switches that lead the cell to commit suicide. However, some cancer cells including brain tumour cells are able to undermine this process by dampening their overactive protein-making machinery. This increases resistance of cancers to chemotherapies. It is not clear how the cell achieves this and the main goal of the work described in this proposal is to understand how this process works at the molecular level. Interestingly, levels of glutamate, a non-essential amino acid may be involved in increasing chemotherapeutic resistance of brain tumours. Aggressive brain tumours such as medulloblastomas and glioblastomas are known to secrete large amounts of glutamate, however its impact on tumour cells has not been well-studied. We will use human tumour cell models to investigate whether glutamate is involved in altering the protein synthesis machinery and if so, determine which proteins are most affected in this context. We will also test whether the efficiency of current chemotherapies that target the protein synthesis machinery can be increased by combined treatment with inhibitors of glutamate signalling which are already in clinical trials for the treatment of autistic disorders.
Competitiondate
201311
Approvedterm2
1 yr 7 mths
Pinamesdelim
Graber, Tyson
Approvedterm
1 an 7 mois
Cihrcontribution2
~ $71,250~ $0~